• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

The proteolytic activation of A (H3N2) Influenza virus hemagglutinin is facilitated by different type II transmembrane serine proteases

tetano

Editor, Senior Moderator
J Virol. 2016 Feb 17. pii: JVI.02693-15. [Epub ahead of print]
[h=1]The proteolytic activation of A (H3N2) Influenza virus hemagglutinin is facilitated by different type II transmembrane serine proteases.[/h] K?hn N[SUP]1[/SUP], Bergmann S[SUP]2[/SUP], Kasnitz N[SUP]3[/SUP], Lambertz RL[SUP]1[/SUP], Keppner A[SUP]4[/SUP], van den Brand JM[SUP]5[/SUP], P?hlmann S[SUP]6[/SUP], Wei? S[SUP]3[/SUP], Hummler E[SUP]4[/SUP], Hatesuer B[SUP]1[/SUP], Schughart K[SUP]7[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] Cleavage of influenza virus hemagglutinin (HA) by host cell proteases is necessary for viral activation and infectivity. In humans and mice, members of the type II transmembrane protease family (TTSP), e.g. TMPRSS2, TMPRSS4 and TMPRSS11d (HAT), have been shown to cleave influenza virus HA for viral activation and infectivity in vitro. Recently, we reported that inactivation of a single HA-activating protease gene, Tmprss2, in knock-out mice inhibits spread of H1N1 influenza viruses. However, after infection of Tmprss2 knock-out mice with H3N2 only a slight increase was observed in survival and mice still lost body weight. In this study, we investigated an additional trypsin-like protease, TMPRSS4. Both TMPRSS2 and TMPRSS4 are expressed in the same cell types of the mouse lung. Deletion of Tmprss4 alone in knock-out mice does not protect them from body weight loss and death upon infection with H3N2 influenza virus. In contrast, Tmprss2[SUP]-/-[/SUP]Tmprss4[SUP]-/-[/SUP] double knock-out mice showed a remarkably reduced virus spread and lung pathology in addition to reduced body weight loss and mortality. Thus, our results identified TMPRSS4 as a second host cell protease that, in addition to TMPRSS2, is able to activate the HA of H3N2 influenza virus HA in vivo.
[h=4]IMPORTANCE:[/h] Influenza epidemics and reoccurring pandemics are responsible for significant global morbidity and mortality. Due to high variability of the virus genome, resistance to available antiviral drugs is frequently observed and new targets for treatment of influenza are needed. Host cell factors essential for processing of the virus hemagglutinin represent very suitable drug targets as the virus is dependent on these host factors for replication. We reported previously that Tmprss2-deficient mice are protected against H1N1 virus infections, but only marginal protection against H3N2 was observed. Here, we show that deletion of two host proteases, Tmprss2 and Tmprss4, strongly reduced viral spread as well as lung pathology and resulted in increased survival after H3N2 infection. Thus, TMPRSS4 represents another host cell factor that is involved in cleavage activation of H3N2 influenza viruses in vivo.
Copyright ? 2016 K?hn et al.


PMID: 26889029 [PubMed - as supplied by publisher]
 
Back
Top Bottom